152 related articles for article (PubMed ID: 11012892)
1. Complement is activated in kidney by endotoxin but does not cause the ensuing acute renal failure.
Cunningham PN; Holers VM; Alexander JJ; Guthridge JM; Carroll MC; Quigg RJ
Kidney Int; 2000 Oct; 58(4):1580-7. PubMed ID: 11012892
[TBL] [Abstract][Full Text] [Related]
2. Expression of a soluble complement inhibitor protects transgenic mice from antibody-induced acute renal failure.
Schiller B; Cunningham PN; Alexander JJ; Bao L; Holers VM; Quigg RJ
J Am Soc Nephrol; 2001 Jan; 12(1):71-79. PubMed ID: 11134252
[TBL] [Abstract][Full Text] [Related]
3. Unrestricted C3 activation occurs in Crry-deficient kidneys and rapidly leads to chronic renal failure.
Bao L; Wang Y; Chang A; Minto AW; Zhou J; Kang H; Haas M; Quigg RJ
J Am Soc Nephrol; 2007 Mar; 18(3):811-22. PubMed ID: 17229915
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific deletion of Crry from mouse proximal tubular epithelial cells increases susceptibility to renal ischemia-reperfusion injury.
Miao J; Lesher AM; Miwa T; Sato S; Gullipalli D; Song WC
Kidney Int; 2014 Oct; 86(4):726-37. PubMed ID: 24850152
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury.
Quigg RJ; He C; Lim A; Berthiaume D; Alexander JJ; Kraus D; Holers VM
J Exp Med; 1998 Oct; 188(7):1321-31. PubMed ID: 9763611
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting the complement system does not reduce injury in renal ischemia reperfusion.
Park P; Haas M; Cunningham PN; Alexander JJ; Bao L; Guthridge JM; Kraus DM; Holers VM; Quigg RJ
J Am Soc Nephrol; 2001 Jul; 12(7):1383-1390. PubMed ID: 11423567
[TBL] [Abstract][Full Text] [Related]
7. The role of ICAM-1 in endotoxin-induced acute renal failure.
Wu X; Guo R; Wang Y; Cunningham PN
Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1262-71. PubMed ID: 17670897
[TBL] [Abstract][Full Text] [Related]
8. Crry deficiency in complement sufficient mice: C3 consumption occurs without associated renal injury.
Ruseva MM; Hughes TR; Donev RM; Sivasankar B; Pickering MC; Wu X; Harris CL; Morgan BP
Mol Immunol; 2009 Feb; 46(5):803-11. PubMed ID: 18947875
[TBL] [Abstract][Full Text] [Related]
9. Mesangial cell complement receptor 1-related protein y limits complement-dependent neutrophil accumulation in immune complex glomerulonephritis.
Bao L; Wang Y; Chen P; Sarav M; Haas M; Minto AW; Petkova M; Quigg RJ
Immunology; 2009 Sep; 128(1 Suppl):e895-904. PubMed ID: 19740350
[TBL] [Abstract][Full Text] [Related]
10. Renal, central nervous system and pancreatic overexpression of recombinant soluble Crry in transgenic mice. A novel means of protection from complement-mediated injury.
Alexander JJ; Lim A; He C; MacDonald RL; Holers VM; Quigg RJ
Immunopharmacology; 1999 May; 42(1-3):245-54. PubMed ID: 10408385
[TBL] [Abstract][Full Text] [Related]
11. Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice.
Guo Z; Chen J; Zeng Y; Wang Z; Yao M; Tomlinson S; Chen B; Yuan G; He S
Front Immunol; 2021; 12():785287. PubMed ID: 35069557
[TBL] [Abstract][Full Text] [Related]
12. Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice.
Bao L; Haas M; Kraus DM; Hack BK; Rakstang JK; Holers VM; Quigg RJ
J Am Soc Nephrol; 2003 Mar; 14(3):670-9. PubMed ID: 12595503
[TBL] [Abstract][Full Text] [Related]
13. DAF/Crry double deficiency in mice exacerbates nephrotoxic serum-induced proteinuria despite markedly reduced systemic complement activity.
Miwa T; Zhou L; Tudoran R; Lambris JD; Madaio MP; Nangaku M; Molina H; Song WC
Mol Immunol; 2007 Jan; 44(1-3):139-46. PubMed ID: 16887189
[TBL] [Abstract][Full Text] [Related]
14. Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma.
Qiao F; Atkinson C; Song H; Pannu R; Singh I; Tomlinson S
Am J Pathol; 2006 Sep; 169(3):1039-47. PubMed ID: 16936276
[TBL] [Abstract][Full Text] [Related]
15. Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion.
Thurman JM; Ljubanović D; Royer PA; Kraus DM; Molina H; Barry NP; Proctor G; Levi M; Holers VM
J Clin Invest; 2006 Feb; 116(2):357-68. PubMed ID: 16444293
[TBL] [Abstract][Full Text] [Related]
16. Crry, a complement regulatory protein, modulates renal interstitial disease induced by proteinuria.
Hori Y; Yamada K; Hanafusa N; Okuda T; Okada N; Miyata T; Couser WG; Kurokawa K; Fujita T; Nangaku M
Kidney Int; 1999 Dec; 56(6):2096-106. PubMed ID: 10594785
[TBL] [Abstract][Full Text] [Related]
17. Cellular specificity of murine renal C3 expression in two models of inflammation.
Ault BH; Colten HR
Immunology; 1994 Apr; 81(4):655-60. PubMed ID: 8039815
[TBL] [Abstract][Full Text] [Related]
18. Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice.
Thurman JM; Ljubanovic D; Edelstein CL; Gilkeson GS; Holers VM
J Immunol; 2003 Feb; 170(3):1517-23. PubMed ID: 12538716
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury.
Laskowski J; Renner B; Le Quintrec M; Panzer S; Hannan JP; Ljubanovic D; Ruseva MM; Borza DB; Antonioli AH; Pickering MC; Holers VM; Thurman JM
Kidney Int; 2016 Jul; 90(1):109-22. PubMed ID: 27165610
[TBL] [Abstract][Full Text] [Related]
20. Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor.
Quigg RJ; Kozono Y; Berthiaume D; Lim A; Salant DJ; Weinfeld A; Griffin P; Kremmer E; Holers VM
J Immunol; 1998 May; 160(9):4553-60. PubMed ID: 9574562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
